176 related articles for article (PubMed ID: 34783620)
21. The burden of disease due to COVID-19 in Sweden 2020-2021: A disability-adjusted life years (DALYs) study.
Shedrawy J; Ernst P; Lönnroth K; Nyberg F
Scand J Public Health; 2023 Jul; 51(5):673-681. PubMed ID: 36941820
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
GBD Chronic Respiratory Disease Collaborators
Lancet Respir Med; 2020 Jun; 8(6):585-596. PubMed ID: 32526187
[TBL] [Abstract][Full Text] [Related]
23. [Trends of burden on ischemic heart disease and epidemiological transition of related risk factors in China, 1990-2017].
Wang CR; Meng XF; Wang CP; Liu SW
Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Oct; 41(10):1703-1709. PubMed ID: 33297630
[No Abstract] [Full Text] [Related]
24. Assessing health determinants worldwide: Econometric analysis of the Global Burden of Diseases Study 2000-18 - Highlighting impactful factors on DALY, YLL, and YLD indicators.
Irandoust K; Daroudi R; Tajvar M; Yaseri M
J Glob Health; 2024 Mar; 14():04051. PubMed ID: 38483443
[TBL] [Abstract][Full Text] [Related]
25. Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: global Burden of Disease Study.
Murray CJ; Lopez AD
Lancet; 1997 May; 349(9062):1347-52. PubMed ID: 9149696
[TBL] [Abstract][Full Text] [Related]
26. Stroke Prevalence, Mortality and Disability-Adjusted Life Years in Children and Youth Aged 0-19 Years: Data from the Global and Regional Burden of Stroke 2013.
Krishnamurthi RV; deVeber G; Feigin VL; Barker-Collo S; Fullerton H; Mackay MT; O'Callahan F; Lindsay MP; Kolk A; Lo W; Shah P; Linds A; Jones K; Parmar P; Taylor S; Norrving B; Mensah GA; Moran AE; Naghavi M; Forouzanfar MH; Nguyen G; Johnson CO; Vos T; Murray CJ; Roth GA;
Neuroepidemiology; 2015; 45(3):177-89. PubMed ID: 26505982
[TBL] [Abstract][Full Text] [Related]
27. Changes in disease burden in Poland between 1990-2017 in comparison with other Central European countries: A systematic analysis for the Global Burden of Disease Study 2017.
Gańczak M; Miazgowski T; Kożybska M; Kotwas A; Korzeń M; Rudnicki B; Nogal T; Andrei CL; Ausloos M; Banach M; Brazinova A; Constantin MM; Dubljanin E; Herteliu C; Hostiuc M; Hostiuc S; Jakovljevic M; Jozwiak JJ; Kissimova-Skarbek K; Król ZJ; Mestrovic T; Miazgowski B; Milevska Kostova N; Naghavi M; Negoi I; Negoi RI; Pana A; Rubino S; Sekerija M; Sierpinski R; Szponar L; Topor-Madry R; Vujcic IS; Widecka J; Widecka K; Wojtyniak B; Zadnik V; Kopec JA
PLoS One; 2020; 15(3):e0226766. PubMed ID: 32119685
[TBL] [Abstract][Full Text] [Related]
28. Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013.
Degenhardt L; Charlson F; Stanaway J; Larney S; Alexander LT; Hickman M; Cowie B; Hall WD; Strang J; Whiteford H; Vos T
Lancet Infect Dis; 2016 Dec; 16(12):1385-1398. PubMed ID: 27665254
[TBL] [Abstract][Full Text] [Related]
29. [Analysis on disease burden of stroke in China and the regions with different sociodemographic index from 1990 to 2017].
Qi JY; Wang CR; Liu M; Liu SW; Wang ZW; Wang CP
Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Aug; 55(8):958-964. PubMed ID: 34445833
[No Abstract] [Full Text] [Related]
30. The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis.
; Slogrove AL; Schomaker M; Davies MA; Williams P; Balkan S; Ben-Farhat J; Calles N; Chokephaibulkit K; Duff C; Eboua TF; Kekitiinwa-Rukyalekere A; Maxwell N; Pinto J; Seage G; Teasdale CA; Wanless S; Warszawski J; Wools-Kaloustian K; Yotebieng M; Timmerman V; Collins IJ; Goodall R; Smith C; Patel K; Paul M; Gibb D; Vreeman R; Abrams EJ; Hazra R; Van Dyke R; Bekker LG; Mofenson L; Vicari M; Essajee S; Penazzato M; Anabwani G; Q Mohapi E; N Kazembe P; Hlatshwayo M; Lumumba M; Goetghebuer T; Thorne C; Galli L; van Rossum A; Giaquinto C; Marczynska M; Marques L; Prata F; Ene L; Okhonskaia L; Rojo P; Fortuny C; Naver L; Rudin C; Le Coeur S; Volokha A; Rouzier V; Succi R; Sohn A; Kariminia A; Edmonds A; Lelo P; Ayaya S; Ongwen P; Jefferys LF; Phiri S; Mubiana-Mbewe M; Sawry S; Renner L; Sylla M; Abzug MJ; Levin M; Oleske J; Chernoff M; Traite S; Purswani M; Chadwick EG; Judd A; Leroy V
PLoS Med; 2018 Mar; 15(3):e1002514. PubMed ID: 29494593
[TBL] [Abstract][Full Text] [Related]
31. Secular Trends in Musculoskeletal Rehabilitation Needs in 191 Countries and Territories From 1990 to 2019.
Chen N; Fong DYT; Wong JYH
JAMA Netw Open; 2022 Jan; 5(1):e2144198. PubMed ID: 35044468
[TBL] [Abstract][Full Text] [Related]
32. [The current status and trend of disease burden of neoplasms in 1990 and 2016 for Beijing people].
Ma AJ; Zhou MG; Zeng XY; Dong Z
Zhonghua Zhong Liu Za Zhi; 2021 Mar; 43(3):351-356. PubMed ID: 33752317
[No Abstract] [Full Text] [Related]
33. Global Trends and Forecast of the Burden of Adverse Effects of Medical Treatment: Epidemiological Analysis Based on the Global Burden of Disease Study.
Khan MA; Soteriades ES; King J; Govender R; Hashim MJ; Masood-Husain S; Javaid SF; Debaib Mohammed Saeed Al Darei S; Dahi Al Sheryani S; Nauman J
Cureus; 2020 Mar; 12(3):e7250. PubMed ID: 32195068
[TBL] [Abstract][Full Text] [Related]
34. Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
GBD 2015 Neurological Disorders Collaborator Group
Lancet Neurol; 2017 Nov; 16(11):877-897. PubMed ID: 28931491
[TBL] [Abstract][Full Text] [Related]
35. Depressive disorders in Brazil: results from the Global Burden of Disease Study 2017.
Bonadiman CSC; Malta DC; de Azeredo Passos VM; Naghavi M; Melo APS
Popul Health Metr; 2020 Sep; 18(Suppl 1):6. PubMed ID: 32993670
[TBL] [Abstract][Full Text] [Related]
36. Growing physical rehabilitation needs in resource-poor world regions: secondary, cross-regional analysis with data from the global burden of disease 2017.
Jesus TS; Arango-Lasprilla JC; Kumar Kamalakannan S; Landry MD
Disabil Rehabil; 2022 Sep; 44(19):5429-5439. PubMed ID: 34086516
[TBL] [Abstract][Full Text] [Related]
37. Physical Rehabilitation Needs in the BRICS Nations from 1990 to 2017: Cross-National Analyses Using Data from the Global Burden of Disease Study.
Jesus TS; Landry MD; Hoenig H; Zeng Y; Kamalakannan S; Britto RR; Pogosova N; Sokolova O; Grimmer K; Louw QA
Int J Environ Res Public Health; 2020 Jun; 17(11):. PubMed ID: 32531949
[No Abstract] [Full Text] [Related]
38. Epidemiological Trends in Alopecia Areata at the Global, Regional, and National Levels.
Wang H; Pan L; Wu Y
Front Immunol; 2022; 13():874677. PubMed ID: 35911734
[TBL] [Abstract][Full Text] [Related]
39. Global, regional and national disability-adjusted life years due to HIV from 1990 to 2019: findings from the Global Burden of Disease Study 2019.
Wu J; Lai T; Han H; Liu J; Wang S; Lyu J
Trop Med Int Health; 2021 Jun; 26(6):610-620. PubMed ID: 33639020
[TBL] [Abstract][Full Text] [Related]
40. The association between sociodemographic status and COPD and asthma mortality, DALY and YLD in southern China, 2005-2015.
Liao TT; Guan WJ; Zheng YJ; Wang Y; Xiao N; Li C; Xu YJ; He ZX; Meng RL; Zheng XY; Lin LF
Public Health; 2022 Nov; 212():102-110. PubMed ID: 36306686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
